Your Source for Venture Capital and Private Equity Financings

VC-funded Company:

Apic Bio
700 Main Street, North
Cambridge, MA 02139
Phone: 857-302-3757
https://www.apic-bio.com/

Apic Bio is committed to finding cures for patients with genetic diseases. The company is a spin-off from the University of Massachusetts Medical School (UMMS) and is based upon nearly 30 years of gene therapy research by Apic's scientific founders. Apic is developing best-in-class treatment options for rare, devastating neurological and liver diseases. Its current pipeline focuses on new and effective treatments for Alpha-1 Antitrypsin Deficiency (Alpha-1, or AATD) and genetic Amyotrophic Lateral Sclerosis (ALS.)

Key Contact
Name
John Reilly
Title
CEO
E-Mail
Funding Events

Date
Amount
Type
Investors
Valuation
01/08/19 $40,000,000 Series A A1ATD Investors
Alpha-1 Project
ALS Investment Fund
Morningside Venture
undisclosed